NEPHROPLUS logo

Nephrocare Health Services Limited Stock Price

NSEI:NEPHROPLUS Community·₹67.7b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

NEPHROPLUS Share Price Performance

₹0
-471.25 (-100.00%)
₹771.25
Fair Value
₹0
-471.25 (-100.00%)
Price ₹0

NEPHROPLUS Community Narratives

·
Fair Value ₹771.25 12.9% undervalued intrinsic discount

Dialysis Demand And International Expansion Will Support A Positive Long Term View

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
·
Fair Value ₹1k 32.8% undervalued intrinsic discount

Rising Dialysis Demand And International Expansion Will Support A Stronger Long Term Outlook

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value ₹660 1.8% overvalued intrinsic discount

Clinic Expansion And International Policy Risks Will Pressure Long Term Dialysis Economics

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
₹771.25
12.9% undervalued intrinsic discount
Revenue
17.77% p.a.
Profit Margin
14.99%
Future PE
54.79x
Price in 2029
₹607.95
₹660
1.8% overvalued intrinsic discount
Revenue
16.11% p.a.
Profit Margin
11.36%
Future PE
65.07x
Price in 2029
₹524.19

Trending Discussion

Updated Narratives

NEPHROPLUS logo

NEPHROPLUS: Index Inclusion And Overseas Expansion Will Drive Future Upside

Fair Value: ₹771.25 12.9% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
NEPHROPLUS logo

Clinic Expansion And International Policy Risks Will Pressure Long Term Dialysis Economics

Fair Value: ₹660 1.8% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
NEPHROPLUS logo

Rising Dialysis Demand And International Expansion Will Support A Stronger Long Term Outlook

Fair Value: ₹1k 32.8% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Excellent balance sheet with reasonable growth potential.

0 Risks
2 Rewards

Nephrocare Health Services Limited Key Details

₹10.0b

Revenue

₹5.9b

Cost of Revenue

₹4.1b

Gross Profit

₹3.3b

Other Expenses

₹768.4m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
7.66
40.86%
7.69%
2.1%
View Full Analysis

About NEPHROPLUS

Founded
2009
Employees
3448
CEO
Rohit Singh
WebsiteView website
www.nephroplus.com

Nephrocare Health Services Limited operates a chain of kidney care clinics that provides dialysis healthcare services with dialysis centres in India, Uzbekistan, Nepal, Kingdom of Saudi Arabia, and the Philippines. It provides In-clinic dialysis, dialysis on call, home hemodialysis, holiday dialysis, and dialysis on wheels services. Nephrocare Health Services Limited was incorporated in 2009 and is based in Hyderabad, India.